News
American Oncology Institute (AOI), a leading cancer hospital network in South Asia, successfully treated a 61-year-old ...
PT-112 monotherapy advances to phase 3 trial in metastatic castration-resistant prostate cancer after positive FDA end of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback